Frontlight ResearchEarly access
Trial site
Cleveland
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 11 trial
- Phase 31 trial
- Status
- Recruiting3 trials
- Lead sponsor
- TG Therapeutics, Inc.3 trials
Running trials
Recruiting
Recruiting
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis3 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
- Myasthenia gravis1 recruiting
- Neuromyelitis optica (NMOSD)1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026